South Africa new coronavirus variant rages alongside vaccine finance debate

“South Africa’s struggle with a new variant of COVID-19 coincides with a debate over how and who will pay for the vaccine. The business community may be one part of the solution, with the government saying the Pfizer jab is too expensive.”

via The Africa Report
More analysis from COVID-19 Africa Watch: